Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
Clinical trial NCT04480099 · UNKNOWN
Trial details
- NCT number
- NCT04480099
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2023-04-20
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.